JPRN-UMIN000008016CompletedPhase 4
Impacts of spironolactone on albuminuria in patients with diabetic nephropathy and hypertension - Spironolactone on albuminuria
Department of Nephrology, Nagoya University Graduate School of Medicine0 sites50 target enrollmentStarted: May 23, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.History of using Spironolactone within 6 months 2.Type 1 diabetes 3.Uncontrolled Hypertension (systolic BP>180mmHg, diastolic>110mmHg) 4. Bilateral renal artery stenosis or renal artery stenosis with unilateral kidney 5.Myocardial infarction, unstable angina and stroke in the past 3 months 6. Heart failure (NYHA 3 or4 ) 7. Potassium > 5.0 mEq/L 8. Cancer 9. liver dysfunction (AST or ALT >100 IU/L) 10. History of renal deterioration under ACE inhibitors/ARBs 11. Pregnancy and lactation 12. Unwillingness of entry 13. Patients with contraindication to study drugs
Investigators
Similar Trials
Completed
Phase 2
Anti Micro Albuminuric Effect of Spironolatone with or without Losartan in Diabetic type II Patientsmicrialbuminuria in diabetic type 2.Glomerular disorders in diabetes mellitusIRCT138806211241N2Mazandaran University of Medical Sciences60
Completed
Not Applicable
anti-albuminuric effect of 1ow-dose spironolactone in patients with diabetic nephropathydiabetic nephropathyJPRN-UMIN000022999Diabetes, Endocrinology and Metabolism, Shinshu University Hospital130
Completed
Not Applicable
The effects of sitagliptin on albuminuria in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000010871niversity of Occupational and Environmental Health100
Not yet recruiting
Not Applicable
Therapeutic measures in Sepsis patients.CTRI/2020/07/026429Maulana Azad Medical College
Completed
Phase 4
Evaluation of effect of spironolactone on proteinuria in kidney transplant patientsIRCT20230516058205N1Esfahan University of Medical Sciences60